Ayala Pharmaceuticals, Inc.
ADXSOTCHealthcare
$0.60
+$0.00(+0.00%)
Market Cap$25707577
P/E Ratio—
52W High$0.801
52W Low$0.0011
Ayala Pharmaceuticals, Inc.（ADXS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADXS · 截至 2026-06-15
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-10 | 2021-10 | 2020-10 | 2019-10 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($48.07M) | ($14.36M) | ($17.86M) | ($26.47M) | ($17.79M) |
| Depreciation & Amort. | $0.37M | $0.31M | $0.99M | $1.98M | $0.15M |
| Stock-Based Comp. | $1.22M | $2.24M | $2.68M | $1.57M | $0.73M |
| Change in Working Capital | $1.13M | $0.31M | $0.42M | ($1.85M) | $1.97M |
| Net Cash from Operations | ($29.48M) | ($15.28M) | ($15.44M) | ($21.94M) | ($14.95M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.20M) | ($0.46M) | ($0.75M) | ($1.33M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.23M | $0.00M |
| Net Cash from Investing | $5.95M | ($0.17M) | ($0.01M) | ($0.75M) | ($1.58M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($5.25M) | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | — | — | — | — | — |
| Net Cash from Financing | $26.00M | ($0.96M) | $31.89M | $15.50M | $7.08M |
| Free Cash Flow | |||||
| Free Cash Flow | ($29.48M) | ($15.48M) | ($15.90M) | ($22.69M) | ($16.28M) |
| FCF Margin %(computed) | — | — | -490.71% | — | -697.51% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · USD · M
深入了解Ayala Pharmaceuticals, Inc.
关于Ayala Pharmaceuticals, Inc.（ADXS）现金流量表
Ayala Pharmaceuticals, Inc. 2023财年经营活动现金流($0.03B)，自由现金流($0.03B)（FCF利润率-226807.69%），资本支出$0.00B。
常见问题
ADXS · 4 问Ayala Pharmaceuticals, Inc. 2023财年自由现金流($0.03B)，同比down90.4%。
ADXS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15